[go: up one dir, main page]

NO873132D0 - MACROCYCLIC COMPOUNDS. - Google Patents

MACROCYCLIC COMPOUNDS.

Info

Publication number
NO873132D0
NO873132D0 NO873132A NO873132A NO873132D0 NO 873132 D0 NO873132 D0 NO 873132D0 NO 873132 A NO873132 A NO 873132A NO 873132 A NO873132 A NO 873132A NO 873132 D0 NO873132 D0 NO 873132D0
Authority
NO
Norway
Prior art keywords
carbon atoms
groups
group
chain
straight
Prior art date
Application number
NO873132A
Other languages
Norwegian (no)
Other versions
NO873132L (en
NO174048C (en
NO174048B (en
Inventor
Heinz Gries
Bernd Raduuechel
Ulrich Speck
Hans-Joachim Weinmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO873132D0 publication Critical patent/NO873132D0/en
Publication of NO873132L publication Critical patent/NO873132L/en
Publication of NO174048B publication Critical patent/NO174048B/en
Publication of NO174048C publication Critical patent/NO174048C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyethers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Compounds of the general formula I <IMAGE> in which Y is a nitrogen or phosphorus atom, A<1> and A<2> are identical or different and are each a straight-chain or branched alkylene group having 2 to 6 carbon atoms, U<1>, U<2>, U<3>, U<4> are identical or different and are each a direct bond or a straight-chain or branched alkylene group having 1 to 6 carbon atoms, D<1>, D<2>, D<3>, D<4> are identical or different and are each an oxygen or sulphur atom, an alkylene group having 1 to 6 carbon atoms or a group N-R<7> where R<7> has the meaning of a hydrogen atom, a straight-chain or branched alkylene chain having 1 to 4 carbon atoms, which carries a COOR<1> group at the end, in which R<1> represents a hydrogen atom or a metal ion equivalent, D<5> has the meaning given for D<1>, D<2>, D<3> and D<4> and the group <IMAGE> where R<5> has the meaning of a hydrogen atom or of a straight-chain or branched, saturated or unsaturated C1-C20-alkylene group which may contain imino, phenyleneoxy, phenyleneimino, amide, ester groups, oxygen, sulphur and/or nitrogen atoms and may be substituted by hydroxyl, mercapto, imino and/or amino groups and has either a functional group or bound via this group a macromolecule B at the end, s and t are integers from 0 to 5, R<2> is hydrogen, a linear or branched, saturated or unsaturated, alkyl, acyl or acylalkyl group of 1 to 16 carbon atoms which is unsubstituted or substitute by one or more hydroxyl or lower alkoxy groups, or is -CH2-X-V where X has the meaning of carbonyl, of a straight-chain or branched alkylene group having 0 to 10 carbon atoms, which is unsubstituted or substituted by one or more hydroxyl or lower alkoxy groups, or of a straight &tilde& chain or branched alkylene group having 2 to 23 carbon atoms which is interrupted by oxygen atoms, V has the meaning <IMAGE> or -COOR<6> in which R<3> and R<4>, independently of one another, are hydrogen, a linear o branched alkyl group having 1 to 16 carbon atoms which is unsubstituted or substituted by one or more hydroxyl or lower alkoxy groups, or R<3> and R<4> together with the nitrogen atom represent a saturated 5- or 6-membered ring which may contain a further hetero atom and R<6> represents hydrogen or a saturated, unsaturated, straight-chain or branched or cyclic hydrocarbon radical having up to 16 carbon atoms or represents an aryl or aralkyl group, or R<2> or R<3> denotes a second macrocycle of the formula I' <IMAGE> which is bound via an alkylene chain (K) containing 2 to 20 carbon atoms, which, if desired carries carbonyl groups at the ends and, if desired, is interrupted by one or more oxygen atoms or R<1>-carboxymethylimino groups or substituted by one or more hydroxyl, lower alkoxy or carboxy-lower alkyl groups, which macrocycle can have a structure which is different from that of the parent structure, or R<2> denotes B or CH2-COB, with the proviso that if Rz represents B or CH2-COB, R<5> denotes a hydrogen atom, that at least two COORi groups are present in the molecule and that two hetero atoms of the macrocycle are each bound to at least two carbon atoms via an alkylene group and functional groups present in the molecule are, if desired conjugated with macromolecules and, if desired free carboxyl groups have been converted with organic or inorganic bases or amino acids and basic groups with inorganic or organic acids to the salts.
NO873132A 1986-07-28 1987-07-27 Macrocyclic compounds and diagnostic agents containing them NO174048C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3625417A DE3625417C2 (en) 1986-07-28 1986-07-28 Tetraazacyclododecane derivatives

Publications (4)

Publication Number Publication Date
NO873132D0 true NO873132D0 (en) 1987-07-27
NO873132L NO873132L (en) 1988-01-29
NO174048B NO174048B (en) 1993-11-29
NO174048C NO174048C (en) 1994-03-09

Family

ID=6306101

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873132A NO174048C (en) 1986-07-28 1987-07-27 Macrocyclic compounds and diagnostic agents containing them

Country Status (13)

Country Link
EP (1) EP0255471B1 (en)
JP (1) JPH0753720B2 (en)
AT (1) ATE80391T1 (en)
CA (1) CA1341176C (en)
DE (2) DE3625417C2 (en)
DK (1) DK171574B1 (en)
ES (1) ES2052599T3 (en)
GR (1) GR3005808T3 (en)
IE (1) IE60677B1 (en)
NO (1) NO174048C (en)
NZ (1) NZ221225A (en)
PT (1) PT85410B (en)
ZA (1) ZA875561B (en)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5132409A (en) * 1987-01-12 1992-07-21 Bracco Industria Chimica S.P.A. Macrocyclic chelating agents and chelates thereof
IT1224416B (en) * 1987-12-24 1990-10-04 Bracco Ind Chimica Spa MACROCYCLIC CHELANTS AND THEIR CHELATES
FR2637895B1 (en) * 1988-10-14 1992-11-06 Guerbet Sa NOVEL NITROGEN CYCLIC LIGANDS, METAL COMPLEXES FORMED BY THESE LIGANDS, DIAGNOSTIC COMPOSITIONS CONTAINING THESE COMPLEXES AND PROCESS FOR THE PREPARATION OF LIGANDS
FR2614020B1 (en) * 1987-04-14 1989-07-28 Guerbet Sa NOVEL NITROGEN CYCLIC LIGANDS, METAL COMPLEXES FORMED BY SUCH LIGANDS, DIAGNOSTIC COMPOSITIONS CONTAINING THESE COMPLEXES AND PROCESS FOR PREPARING LIGANDS.
US5049667A (en) * 1987-04-14 1991-09-17 Guerbet S.A. Nitrogen-containing cyclic ligands
DE3713842A1 (en) * 1987-04-22 1988-11-17 Schering Ag SUBSTITUTED CYCLIC COMPLEX MAKERS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
ES2086445T3 (en) * 1987-07-16 1996-07-01 Nycomed Imaging As AMINO CARBOXYLIC ACIDS AND THEIR DERIVATIVES.
US5531978A (en) * 1987-07-16 1996-07-02 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
GB8719042D0 (en) 1987-08-12 1987-09-16 Parker D Conjugate compounds
GB8719041D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
JPH0720989B2 (en) * 1988-05-25 1995-03-08 アメリカ合衆国 Macrocyclic chelate conjugates and diagnostic test methods
ATE120457T1 (en) * 1988-06-24 1995-04-15 Dow Chemical Co MACROCYCLIC BIFUNCTIONAL CHELATING AGENTS, COMPLEXES THEREOF AND THEIR CONJUGATE ANTIBODIES.
ZA894792B (en) * 1988-06-24 1991-04-24 Dow Chemical Co Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
US5756065A (en) * 1988-06-24 1998-05-26 The Dow Chemical Company Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
DE4001655A1 (en) * 1990-01-18 1991-07-25 Schering Ag 6-RING MACROCYCLIC TETRAAZA COMPOUNDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL PRODUCTS CONTAINING THEM
US4889931A (en) * 1988-09-27 1989-12-26 Salutar, Inc. Manganese (II) chelate manufacture
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
US5342936A (en) * 1989-02-10 1994-08-30 David Parker Tetra-aza macrocycles and processes for their preparation
JPH03504510A (en) * 1989-02-10 1991-10-03 セルテック リミテッド Azamacrocycle and its manufacturing method
US5247077A (en) * 1989-06-23 1993-09-21 Celltech Limited Tri-aza macrocycles and processes for their preparation
GB9320277D0 (en) * 1993-10-01 1993-11-17 Nycomed Salutar Inc Chelants
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
US5446145A (en) * 1990-01-19 1995-08-29 Nycomed Salutar, Inc. Polychelant compounds
US5650133A (en) * 1990-01-19 1997-07-22 Nycomed Salutar Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality
US5972307A (en) * 1989-10-23 1999-10-26 Nycomed Salutar, Inc. Dichelants
JP3250220B2 (en) * 1989-10-23 2002-01-28 ニコムド サルター インコーポレーテッド Multi-site metal chelators
AU625529B2 (en) * 1989-12-22 1992-07-16 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
AU6709390A (en) * 1989-12-22 1991-06-27 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-tris-carboxymethyl -1,4,7,10-tetraazacyclododecane
CH679742A5 (en) * 1990-01-09 1992-04-15 Byk Gulden Lomberg Chem Fab
US5679810A (en) * 1990-01-19 1997-10-21 Salutar, Inc. Linear oligomeric polychelant compounds
DE4009119A1 (en) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
EP0522007A4 (en) * 1990-03-26 1993-06-16 Us Commerce A fonctionalized complexand
DK0455380T3 (en) * 1990-04-18 1997-02-03 Celltech Therapeutics Ltd Tetraaza Macrocycles, Methods of Preparation and Their Use for Magnetic Resona ns Visualization
US5684135A (en) * 1990-04-18 1997-11-04 Celltech Therapeutics Limited Conjugate compounds containing aza-macro-cycles and processes for their preparation
CA2039399C (en) * 1990-04-25 2000-09-05 C. Allen Chang Dual functioning excipient for metal chelate contrast agents
US5162109A (en) * 1990-09-13 1992-11-10 Mallinckrodt Medical, Inc. Magnetic resonance imaging agents
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
DE4035760A1 (en) * 1990-11-08 1992-05-14 Schering Ag MONO-N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODECAN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
EP0660925A1 (en) * 1990-11-21 1995-07-05 Mallinckrodt Medical, Inc. Alkoxyamide derivatized chelates for mri
DE4115789A1 (en) * 1991-05-10 1992-11-12 Schering Ag MACROCYCLIC POLYMER COMPLEX IMAGERS, THEIR COMPLEXES, METHOD FOR THEIR PRODUCTION AND THE PHARMACEUTICAL AGENTS CONTAINING THEM
DE4237943C2 (en) * 1992-11-06 1997-10-23 Schering Ag Process for the preparation of metal complexes of N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane Derivatives
DE4140779A1 (en) * 1991-12-06 1993-06-09 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De METHOD FOR PRODUCING MONO-N SUBSTITUTED TETRAAZAMACROCYCLES
CA2092596A1 (en) * 1992-03-27 1993-09-28 Kan Kubomura Tetraazacyclododecane derivative and its use
US5310535A (en) * 1992-04-24 1994-05-10 The Dow Chemical Company Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
DE4218744C2 (en) * 1992-06-04 1997-11-06 Schering Ag Process for the preparation of N-β-hydroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecane and N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives and their metal complexes
WO1994008630A1 (en) * 1992-10-13 1994-04-28 Mallinckrodt Medical, Inc. Novel compositions for magnetic resonance imaging
DE4317588C2 (en) * 1993-05-24 1998-04-16 Schering Ag Macrocyclic metal complexes containing fluorine, process for their preparation and their use
DE4318369C1 (en) * 1993-05-28 1995-02-09 Schering Ag Use of macrocyclic metal complexes as temperature probes
GB9318550D0 (en) * 1993-09-07 1993-10-20 Nycomed Salutar Inc Chelants
US5358704A (en) * 1993-09-30 1994-10-25 Bristol-Myers Squibb Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents
DE4340809C2 (en) * 1993-11-24 2000-08-03 Schering Ag 1.4,7,10-tetraazacyclododecane derivatives, pharmaceutical compositions containing them and process for their preparation
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
CA2225453C (en) * 1995-06-26 2004-12-14 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
DE19652386A1 (en) * 1996-12-04 1998-06-10 Schering Ag Process for the preparation of metal complex carboxamides
DE19744003B4 (en) * 1997-09-26 2004-07-08 Schering Ag Contrast agent for infarct and necrosis imaging
IT1297035B1 (en) * 1997-12-30 1999-08-03 Bracco Spa 1,4,7,10-TETRAAZACICLODODECAN-1,4-DIACETIC ACID DERIVATIVES
DE19849465A1 (en) * 1998-10-21 2000-04-27 Schering Ag New dimeric ion pairs containing cationic and anionic metal complexes; useful as low viscosity contrast agents for X-ray, magnetic resonance and radiodiagnostic techniques, and as radiotherapy agents
WO2000076556A2 (en) 1999-06-11 2000-12-21 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
WO2001028982A1 (en) * 1999-10-22 2001-04-26 Mitsubishi Pharma Corporation Diethylenetriaminepenta acetic acid derivatives
FR2802928B1 (en) * 1999-12-22 2003-01-31 Air Liquide POLYAZACYCLOALCANES POSSIBLY GRAFT ON A SOLID MATRIX, ORGANOMETALLIC COMPLEXES INCORPORATING THEM AS LIGANDS. USE OF SAID COMPOUNDS FOR THE EXTRACTION OF HEAVY METALS
JP2004536034A (en) 2001-01-08 2004-12-02 ネオルクス コーポレイション Therapeutic and diagnostic compounds, compositions and methods
WO2006124726A2 (en) 2005-05-12 2006-11-23 The General Hospital Corporation Novel biotinylated compositions
DE102007002726A1 (en) 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft New cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them
US10189803B2 (en) 2008-02-22 2019-01-29 Illinois Institute Of Technology Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
WO2010011367A2 (en) * 2008-02-22 2010-01-28 Illinois Institute Of Technology Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
US9446995B2 (en) 2012-05-21 2016-09-20 Illinois Institute Of Technology Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
US10556873B2 (en) 2008-02-22 2020-02-11 Illinois Institute Of Technology Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
DE102009053171B4 (en) 2009-11-04 2011-07-21 Bayer Schering Pharma Aktiengesellschaft, 13353 Process for the preparation of the calcium complex of dihydroxy-hydroxy-methylpropyl-tetraazacyclododecane-triacetic acid (Calcobutrol)
WO2011054480A1 (en) 2009-11-09 2011-05-12 Bayer Schering Pharma Aktiengesellschaft Gadobutrol production by means of a ceramic membrane
DE102009057274B4 (en) 2009-12-02 2011-09-01 Bayer Schering Pharma Aktiengesellschaft Gadobutrol preparation using trioxobicyclo-octane
DE102010013833A1 (en) 2010-03-29 2011-09-29 Bayer Schering Pharma Aktiengesellschaft Producing gadolinium complex of N-(hydroxymethyl-dihydroxypropyl)-triscarboxymethyl-tetraazacyclododecane useful as magnetic resonance imaging contrast agent, comprises e.g. reacting cyclic compound with dimethylformamide dimethylacetal
DK2896405T3 (en) 2011-04-21 2020-04-06 Bayer Ip Gmbh Preparation of high purity gadobutrol
EP2890788A1 (en) 2012-08-31 2015-07-08 The General Hospital Corporation Biotin complexes for treatment and diagnosis of alzheimer's disease
WO2015051362A1 (en) 2013-10-04 2015-04-09 Illinois Institute Of Technology Multifunctional chelators, complexes, and compositions thereof, and methods of using same
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CA3002897C (en) * 2015-12-10 2022-03-29 Bracco Imaging Spa Dimeric contrast agents
DK3519394T3 (en) 2016-09-27 2020-08-17 Bayer Pharma AG METHOD OF PREPARING THE CRYSTALLINIC FORM OF MODIFICATION A OF CALCOBUTROL
CA3044877A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
HUE056114T2 (en) * 2016-12-12 2022-01-28 Bracco Imaging Spa Dimeric contrast agents
CN108358954B (en) * 2018-01-17 2019-10-29 南开大学 A kind of chirality rare earth-NO free radical single-chain magnets and preparation method thereof
EP3883613A1 (en) 2018-11-23 2021-09-29 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
CN110357828B (en) * 2019-08-13 2021-03-19 牡丹江医学院 A kind of nuclear magnetic resonance contrast agent and its preparation method and use
CN118955414B (en) * 2024-10-17 2025-03-18 南昌大学 Amphiphilic Eu complex and its preparation method and application in detecting tetracycline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194579C (en) * 1983-01-21 2002-08-05 Schering Ag Diagnostic.
DE3316703A1 (en) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen ORAL CONTRAST AGENT FOR MRI MRI AND THE PRODUCTION THEREOF
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
DE3772785D1 (en) * 1986-01-23 1991-10-17 Squibb & Sons Inc 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECAN AND ANALOG.
GB8603537D0 (en) * 1986-02-13 1986-03-19 Parker D Conjugate compound

Also Published As

Publication number Publication date
IE60677B1 (en) 1994-08-10
NO873132L (en) 1988-01-29
AU7621787A (en) 1988-02-04
CA1341176C (en) 2001-01-30
EP0255471B1 (en) 1992-09-09
NZ221225A (en) 1990-09-26
PT85410B (en) 1990-06-29
DE3781620D1 (en) 1992-10-15
DE3625417C2 (en) 1998-10-08
ZA875561B (en) 1989-03-29
ATE80391T1 (en) 1992-09-15
PT85410A (en) 1987-08-01
GR3005808T3 (en) 1993-06-07
NO174048C (en) 1994-03-09
JPS6341468A (en) 1988-02-22
DK393387A (en) 1988-01-29
AU604249B2 (en) 1990-12-13
DK171574B1 (en) 1997-01-20
ES2052599T3 (en) 1994-07-16
EP0255471A1 (en) 1988-02-03
IE872038L (en) 1988-01-28
JPH0753720B2 (en) 1995-06-07
NO174048B (en) 1993-11-29
DE3625417A1 (en) 1988-02-11
DK393387D0 (en) 1987-07-28

Similar Documents

Publication Publication Date Title
DK393387D0 (en) MACROCYCLIC COMPOUNDS
KR910007704A (en) Fibrinogen receptor antagonist
GR3005807T3 (en)
ATE150659T1 (en) USE OF ORGANOFUNCTIONALLY MODIFIED POLYSILOXANES FOR DEFOAMING DIESEL FUEL
MX165512B (en) CARBAMATE ADDITIVE FOR LUBRICATING COMPOSITION
ATE53860T1 (en) FUEL MIXTURE.
ES2035261T3 (en) COMPOSITIONS OF OIL AND FUEL OIL CRUDES.
EP0250358A3 (en) Novel complex compounds
EP0341925A3 (en) An inorganic filler containing polyolefin composition
DE69203551D1 (en) Biodegradable copolyester of 4-hydroxyproline and pharmaceutical composition containing it.
DE3772685D1 (en) USE OF RARE EARTH MIXTURES TO STABILIZE FUELS FOR DIESEL ENGINES.
ATE189215T1 (en) COMPOSITIONS, CONCENTRATES, LUBRICANT COMPOSITIONS, FUEL COMPOSITIONS, AND FUEL ECONOMY IMPROVEMENT METHOD OF INTERNAL COMBUSTION ENGINES
ATE38675T1 (en) PHOSPHATE ESTER DERIVATIVES AND THEIR USE AS AN ANTI-CANCER AGENT.
FR2616663B1 (en) NOVEL NITROGEN POLYCYCLIC STRUCTURE TRIPEPTIDES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
GB1489849A (en) 4,4&#39;-bi-piperidylidene derivatives and their use as polymer stabilizers
DE69006552D1 (en) Formal compounds, fuel additives and fuel mixtures.
KR860002443A (en) Method for preparing anthracene derivative
KR840001154A (en) Method for preparing 1,2-dithiol-3-ylidene ammonium derivative
KR860007222A (en) Method for preparing benzo [a] phenazine derivative
ES2012763B3 (en) WELDING COMPOSITIONS.
KR890010089A (en) Curable Resin Composition
DE3572815D1 (en) 1,3-DITHIOLE DERIVATIVES

Legal Events

Date Code Title Description
MK1K Patent expired